Lv1
90 积分 2023-07-04 加入
Treating Head and Neck Cancer in the Age of Immunotherapy: A 2023 Update
4天前
已完结
Antitumor Effect of 89Sr for Multiple Bone Metastases of Breast Cancer
5天前
已关闭
Exploring the frontiers: tumor immune microenvironment and immunotherapy in head and neck squamous cell carcinoma
15天前
已完结
Acquired resistance to immunotherapy and chemoradiation in MYC amplified head and neck cancer
15天前
已完结
Mechanisms of Resistance and Therapeutic Perspectives in Immunotherapy for Advanced Head and Neck Cancers
15天前
已完结
Precision oncology: current and future platforms for treatment selection
7个月前
已完结
Data from Transcriptomic Heterogeneity of <i>EGFR</i>-Mutant Non–Small Cell Lung Cancer Evolution Toward Small-Cell Lung Cancer
9个月前
已关闭
Advances of Amifostine in Radiation Protection: Administration and Delivery
1年前
已完结
Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trial
1年前
已完结
Increased alcohol dehydrogenase 1 activity promotes longevity
1年前
已完结
Predicting EGFR and PD-L1 Status in NSCLC Patients Using Multitask AI System Based on CT Images
皖公网安备34019202002308
